| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_351266bb714df09224a7007992c9998a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c59eccbb6de22c1d3c8b68f789e58e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_048120d2d7536e9854588bb1fb88fbd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0607c02c591c0881c2f44175cb4a1a8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_338e90b0d9255aef9684c28b312a557d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate |
2007-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ac5c151a5fb2cecb8874117e9fe0f7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_404d95f675a2cc7dc8d9ac9731a13a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40524677cf9079cbb8efa0cdb08b7e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a703377a7401f5714ff7196c73206b0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfc5f962847bb8fee62da762361e7daf |
| publicationDate |
2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008068173-A1 |
| titleOfInvention |
4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| abstract |
The present invention relates to compounds of formula (I) wherein R1 and R2 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-022746-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101538239-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8912179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012029070-A1 |
| priorityDate |
2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |